文献速递免疫规划卫生政策与健康促进

高收入地区轮状病毒疫苗接种成本效果的系统综述:应用动态传播建模技术

Systematic review of rotavirus vaccination cost-effectiveness in high income settings utilising dynamic transmission modelling techniques.
PubMed 文献 · Vaccine · 2023-07-19

本系统综述检索2002年以来多个数据库,纳入4项基于动态传播模型的高收入国家轮状病毒疫苗接种成本效果研究,均比较五价或单价疫苗与不干预。所有研究均为成本-效用分析,报告每获得质量调整生命年(QALY)的增量成本;在模型纳入群体保护效益时,相对于各国支付意愿阈值,轮状病毒疫苗接种均具成本效果。

要点

  • 共纳入4项基于动态传播模型的经济学评价,均为成本-效用分析。
  • 研究地点为英格兰和威尔士、法国、挪威和美国。
  • 纳入群体保护效益时,接种相对不接种具成本效果。

核心结论

  • 在高收入地区、轮状病毒胃肠炎所致儿童死亡率接近零的情况下,所有使用动态传播模型的研究均发现轮状病毒疫苗接种具成本效果。
  • 本综述提示建模选择影响轮状病毒疫苗接种的成本效果结果,动态传播模型比静态模型更可能捕捉疫苗接种的全面影响。

研究设计与样本

  • 系统综述,检索CEA Registry、MEDLINE、Embase、卫生技术评估数据库、Scopus和英国国家卫生服务经济学评价数据库2002年以来发表的研究。
  • 纳入标准为基于动态传播模型、聚焦高收入国家、口服轮状病毒活疫苗、5岁及以下儿童的全经济学评价研究。
  • 采用健康经济标准共识(CHEC)清单和Philips清单评价纳入研究的质量和偏倚风险,方案前瞻性注册于PROSPERO(CRD42020208406)。

主要发现

  • 共识别4项经济学评价,研究地点包括英格兰和威尔士、法国、挪威和美国。
  • 所有研究均比较五价或单价轮状病毒疫苗与不干预。
  • 所有研究均为成本-效用分析,报告每获得质量调整生命年(QALY)的增量成本。
  • 在模型框架纳入群体保护效益时,纳入研究一致认为轮状病毒疫苗接种相对不接种、相对于各国支付意愿阈值具成本效果。

临床怎么用

  • 本综述结果可为高收入地区关于实施轮状病毒疫苗接种规划的政策决策提供参考。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This systematic review presents cost-effectiveness studies of rotavirus vaccination in high-income settings based on dynamic transmission modelling to inform policy decisions about implementing rotavirus vaccination programmes. METHODS: We searched CEA Registry, MEDLINE, Embase, Health Technology Assessment Database, Scopus, and the National Health Service Economic Evaluation Database for studies published since 2002. Full economic evaluation studies based on dynamic transmission models, focusing on high-income countries, live oral rotavirus vaccine and children ≤ 5 years of age were eligible for inclusion. Included studies were appraised for quality and risk of bias using the Consensus on Health Economic Criteria (CHEC) list and the Philips checklist. The review protocol was prospectively registered with PROSPERO (CRD42020208406). RESULTS: A total of four economic evaluations were identified. Study settings included England and Wales, France, Norway, and the United States. All studies compared either pentavalent or monovalent rotavirus vaccines to no intervention. All studies were cost-utility analyses that reported incremental cost per quality-adjusted life year (QALY) gained. Included studies consistently concluded that rotavirus vaccination is cost-effective compared with no vaccination relative to the respective country's willingness to pay threshold when herd protection benefits are incorporated in the modelling framework. CONCLUSIONS: Rotavirus vaccination was found to be cost-effective in all identified studies that used dynamic transmission models in high-income settings where child mortality rates due to rotavirus gastroenteritis are close to zero. Previous systematic reviews of economic evaluations considered mostly static models and had less conclusive findings than the current study. This review suggests that modelling choices influence cost-effectiveness results for rotavirus vaccination. Specifically, the review suggests that dynamic transmission models are more likely to account for the full impact of rotavirus vaccination than static models in cost-effectiveness analyses.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Jesudason T, Rodarte A, Tordrup D, et al. Systematic review of rotavirus vaccination cost-effectiveness in high income settings utilising dynamic transmission modelling techniques. Vaccine. 2023. PMID: 37479614. doi:10.1016/j.vaccine.2023.06.064

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。